Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Irene Lizano-Díez & Silvia Paz Ruiz. (2021) Analysis of the Financial Impact of Using Cangrelor on the Safety and Efficacy Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Whom Oral Therapy with P2Y12 Inhibitors is Not Feasible or Desirable, in Spain. ClinicoEconomics and Outcomes Research 13, pages 77-87.
Read now
Read now
Michael Abdelnoor, Jack Gunnar Andersen, Harald Arnesen & Odd Johansen. (2017) Early discharge compared with ordinary discharge after percutaneous coronary intervention – a systematic review and meta-analysis of safety and cost. Vascular Health and Risk Management 13, pages 101-109.
Read now
Read now
Jean Ferrieres, Ameet Bakhai, Andres Iñiguez, Claude Schmitt, Magali Sartral, Mark Belger & Uwe Zeymer. (2010) Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Current Medical Research and Opinion 26:9, pages 2193-2202.
Read now
Read now
Articles from other publishers (60)
Ting-Yi Lin, Yi-Fen Lai, Wu-Chien Chien, Yi-Hao Chen, Chien-An Sun, Chi-Hsiang Chung, Jiann-Torng Chen & Ching-Long Chen. (2022) Association Between Endophthalmitis and the Incidence of Acute Coronary Syndrome in Patients With Ankylosing Spondylitis: A Nationwide, Population-Based Cohort Study. Frontiers in Immunology 13.
Crossref
Crossref
Shahrul Bariyah Hamid & Auni Fatin Abd Hamid. 2022. Research Anthology on Recent Advancements in Ethnopharmacology and Nutraceuticals. Research Anthology on Recent Advancements in Ethnopharmacology and Nutraceuticals
810
839
.
Sherif W. Ayad, Tarek H. El Zawawy, Mohamed I. Lotfy, Ahmed M. Naguib & Ahmed M. El Amrawy. (2021) Incidence and impact of totally occluded culprit coronary artery in patients with non-ST segment elevation myocardial infarction acute coronary syndrome. The Egyptian Heart Journal 73:1.
Crossref
Crossref
Soshiro Ogata, Kyohei Marume, Michikazu Nakai, Ryota Kaichi, Masanobu Ishii, Sou Ikebe, Takayuki Mori, Soichi Komaki, Hiroaki Kusaka, Reiko Toida, Kazumasa Kurogi, Yoshitaka Iwanaga, Takao Yano, Nobuyasu Yamamoto & Yoshihiro Miyamoto. (2021) Incidence Rate of Acute Coronary Syndrome Including Acute Myocardial Infarction, Unstable Angina, and Sudden Cardiac Death in Nobeoka City for the Super-Aged Society of Japan. Circulation Journal 85:10, pages 1722-1730.
Crossref
Crossref
M.N. Solís-Marquínez, J.J. Rondán-Murillo, M. Pérez-Otero, J.M. Vegas-Valle, Í. Lozano Martínez-Luengas & J. Morís-de la Tassa. (2021) Impact of creating a hemodynamics room, a coronary care unit, and a primary angioplasty program on the prognosis of acute coronary syndrome in a district hospital. Revista Clínica Española (English Edition) 221:4, pages 187-197.
Crossref
Crossref
M.N. Solís-Marquínez, J.J. Rondán-Murillo, M. Pérez-Otero, J.M. Vegas-Valle, Í. Lozano Martínez-Luengas & J. Morís-de la Tassa. (2021) Impacto de la creación de una sala de hemodinámica, una unidad coronaria y un programa de angioplastia primaria en el pronóstico del síndrome coronario agudo en un hospital comarcal. Revista Clínica Española 221:4, pages 187-197.
Crossref
Crossref
Luiz Sérgio Fernandes de Carvalho, Silvio Gioppato, Marta Duran Fernandez, Bernardo Carvalho Trindade, José Carlos Quinaglia e Silva, Rebeca Gouget Sérgio Miranda, José Roberto Matos de Souza, Wilson Nadruz, Sandra Eliza Fontes Avila & Andrei Carvalho Sposito. (2020) Machine Learning Improves the Identification of Individuals With Higher Morbidity and Avoidable Health Costs After Acute Coronary Syndromes. Value in Health 23:12, pages 1570-1579.
Crossref
Crossref
Jose Antonio Robles-Zurita, Andrew Briggs, Dikshyanta Rana, Zahidul Quayyum, Keith G. Oldroyd, Uwe Zeymer, Steffen Desch, Suzanne de Waha-Thiele & Holger Thiele. (2020) Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. The European Journal of Health Economics 21:8, pages 1197-1209.
Crossref
Crossref
Pau Redón, Atif Shahzad, Talha Iqbal & William Wijns. (2020) Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review. Sensors 20:17, pages 5006.
Crossref
Crossref
Răzvan-Andrei Licu, Emanuel Blîndu, Diana Opincariu & Theodora Benedek. (2020) Vulnerable Plaques Producing an Acute Coronary Syndrome Exhibit a Different CT Phenotype than Those That Remain Silent. Journal Of Cardiovascular Emergencies 6:2, pages 26-34.
Crossref
Crossref
Tong Su, Xiaonan Shao, Xiaopu Zhang, Zhijun Han, Chengjian Yang & Xun Li. (2019) Circulating microRNA-1 in the diagnosis and predicting prognosis of patients with chest pain: a prospective cohort study. BMC Cardiovascular Disorders 19:1.
Crossref
Crossref
Laura Pirhonen, Kristian Bolin, Elisabeth Hansson Olofsson, Andreas Fors, Inger Ekman, Karl Swedberg & Hanna Gyllensten. (2019) Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial. PharmacoEconomics - Open 3:4, pages 495-504.
Crossref
Crossref
Maria Velleca, Graca Costa, Laura Goldstein, Moe Bishara & Lee Ming Boo. (2019) A Review of the Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic across Europe. EMJ Cardiology, pages 110-118.
Crossref
Crossref
Sudhakar George, Eunice N. C. Onwordi, Amr Gamal & Azfar Zaman. (2019) Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome. Clinical Drug Investigation 39:6, pages 495-502.
Crossref
Crossref
Angelo Silverio, Pierpaolo Cavallo, Roberta De Rosa & Gennaro Galasso. (2019) Big Health Data and Cardiovascular Diseases: A Challenge for Research, an Opportunity for Clinical Care. Frontiers in Medicine 6.
Crossref
Crossref
Shahrul Bariyah Hamid & Auni Fatin Abd Hamid. 2019. Nutraceutical and Functional Foods in Disease Prevention. Nutraceutical and Functional Foods in Disease Prevention
126
165
.
Tong Su, Xiaonan Shao, Xiaopu Zhang, Zhijun Han, Chengjian Yang & Xun Li. (2019) Initial Concentrations of miR-1 MicroRNA Precursor and High-Sensitivity Troponin in the Diagnosis of Non-ST Myocardial Infarction among Patients with and Those without Chronic Kidney Disease. Cardiorenal Medicine 9:5, pages 274-283.
Crossref
Crossref
Christian Schmidt, Alper Öner, Miriam Mann, Katja Krockenberger, Melanie Abbondanzieri, Bernard Brandewiede, Armin Brüge, Gisela Hostenkamp, Axel Kaiser, Henriette Neumeyer & Andreas Ziegler. (2018) A novel integrated care concept (NICC) versus standard care in the treatment of chronic cardiovascular diseases: protocol for the randomized controlled trial CardioCare MV. Trials 19:1.
Crossref
Crossref
Raphael TwerenboldPatrick BadertscherJasper BoeddinghausThomas NestelbergerKarin WildiChristian PuelacherZaid SabtiMaria Rubini GimenezSandra TschirkyJeanne du Fay de LavallazNikola KozhuharovLorraine SazgaryDeborah MuellerTobias BreidthardtIvo StrebelDayana Flores WidmerSamyut ShresthaÒscar MiróF. Javier Martín-SánchezBeata MorawiecJiri ParenicaNicolas GeigyDagmar I. KellerKatharina RentschArnold von EckardsteinStefan OsswaldTobias ReichlinChristian Mueller. (2018) 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction. Circulation 137:5, pages 436-451.
Crossref
Crossref
Abdur R. Khan, Harsh Golwala, Avnish Tripathi, Aref A. Bin Abdulhak, Chirag Bavishi, Haris Riaz, Vishnu Mallipedi, Ambarish Pandey & Deepak L. Bhatt. (2017) Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. European Heart Journal 38:41, pages 3082-3089.
Crossref
Crossref
Raphael Twerenbold, Cedric Jaeger, Maria Rubini Gimenez, Karin Wildi, Tobias Reichlin, Thomas Nestelberger, Jasper Boeddinghaus, Karin Grimm, Christian Puelacher, Berit Moehring, Gil Pretre, Nicolas Schaerli, Isabel Campodarve, Katharina Rentsch, Stephan Steuer, Stefan Osswald & Christian Mueller. (2016) Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction. European Heart Journal 37:44, pages 3324-3332.
Crossref
Crossref
Emad Abu-Assi, Andrea López-López, Violeta González-Salvado, Alfredo Redondo-Diéguez, Carlos Peña-Gil, Noelia Bouzas-Cruz, Sergio Raposeiras-Roubín, Rami Riziq-Yousef Abumuaileq, José M. García-Acuña & José R. González-Juanatey. (2016) El riesgo de eventos cardiovasculares tras un evento coronario agudo persiste elevado a pesar de la revascularización, especialmente durante el primer año. Revista Española de Cardiología 69:1, pages 11-18.
Crossref
Crossref
Emad Abu-Assi, Andrea López-López, Violeta González-Salvado, Alfredo Redondo-Diéguez, Carlos Peña-Gil, Noelia Bouzas-Cruz, Sergio Raposeiras-Roubín, Rami Riziq-Yousef Abumuaileq, José M. García-Acuña & José R. González-Juanatey. (2016) The Risk of Cardiovascular Events After an Acute Coronary Event Remains High, Especially During the First Year, Despite Revascularization. Revista Española de Cardiología (English Edition) 69:1, pages 11-18.
Crossref
Crossref
Sameer Bansilal, José M. Castellano & Valentín Fuster. (2016) WITHDRAWN: Global burden of CVD: Focus on secondary prevention of cardiovascular disease. International Journal of Cardiology.
Crossref
Crossref
Sameer Bansilal, José M. Castellano & Valentín Fuster. (2015) Global burden of CVD: focus on secondary prevention of cardiovascular disease. International Journal of Cardiology 201, pages S1-S7.
Crossref
Crossref
Zaher Fanari, Sandra Weiss & William S. Weintraub. (2015) Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review. American Journal of Cardiovascular Drugs 15:6, pages 415-427.
Crossref
Crossref
Janet R. Davies. (2015) Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?. EMJ Diabetes, pages 31-38.
Crossref
Crossref
Milan Baustein, Miroslav Bartak, Tomas Janota & Vladimir Rogalewicz. (2015) The cost of acute myocardial infarction treatment in the Czech Republic — The case of General University Hospital in Prague. The cost of acute myocardial infarction treatment in the Czech Republic — The case of General University Hospital in Prague.
José Luis López Sendón, Magda Heras, Francisco Javier Carrera Hueso, Max Brosa & Margarita Capel. (2015) Análisis coste-efectividad del uso de ticagrelor frente a clopidogrel en el tratamiento del síndrome coronario agudo en España. PharmacoEconomics Spanish Research Articles 12:4, pages 137-146.
Crossref
Crossref
F. Z. Abdullaev, V. Sh. Mamedov, I. M. Bagirov, I. D. Geybatov, L. S. Shikhieva & N. Dzh Kazimzade. (2015) Features of ischemic heart disease and myocardial revascularization in patients younger than 40 years. Kardiologiya i serdechno-sosudistaya khirurgiya 8:2, pages 21.
Crossref
Crossref
Dennis H.M. Kusters, Jan Tegtmeier, Leon J. Schurgers & Chris P.M. Reutelingsperger. 2015. Inflammation in Heart Failure. Inflammation in Heart Failure
131
142
.
C. B. Giorda, A. Nicolucci, F. Pellegrini, C. K. Kristiansen, B. Hunt, W. J. Valentine & G. Vespasiani. (2014) Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis. Diabetic Medicine 31:5, pages 615-623.
Crossref
Crossref
Fabiola Olivieri, Roberto Antonicelli, Liana Spazzafumo, Gabriele Santini, Maria Rita Rippo, Roberta Galeazzi, Simona Giovagnetti, Yuri D'Alessandra, Fiorella Marcheselli, Maurizio C. Capogrossi & Antonio Domenico Procopio. (2014) Admission levels of circulating miR-499-5p and risk of death in elderly patients after acute non-ST elevation myocardial infarction. International Journal of Cardiology 172:2, pages e276-e278.
Crossref
Crossref
Paul Wright & Sotiris Antoniou. (2013) Acute coronary syndrome: potent oral antiplatelets. Nurse Prescribing 11:8, pages 397-400.
Crossref
Crossref
Nikos Maniadakis, Georgia Kourlaba, Dennis V. Cokkinos, Aggeliki Angeli & John Kyriopoulos. (2012) The economic burden of atherothrombosis in Greece: results from the THESIS study. The European Journal of Health Economics 14:4, pages 655-665.
Crossref
Crossref
Irene R. Dégano, Roberto Elosua & Jaume Marrugat. (2013) Epidemiología del síndrome coronario agudo en España: estimación del número de casos y la tendencia de 2005 a 2049. Revista Española de Cardiología 66:6, pages 472-481.
Crossref
Crossref
Irene R. Dégano, Roberto Elosua & Jaume Marrugat. (2013) Epidemiology of Acute Coronary Syndromes in Spain: Estimation of the Number of Cases and Trends From 2005 to 2049. Revista Española de Cardiología (English Edition) 66:6, pages 472-481.
Crossref
Crossref
Ulrike Theidel, Christian Asseburg, Evangelos Giannitsis & Hugo Katus. (2013) Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany. Clinical Research in Cardiology 102:6, pages 447-458.
Crossref
Crossref
Paul WrightSotiris Antoniou. (2013) Novel oral antiplatelets for acute coronary syndrome. British Journal of Cardiac Nursing 8:4, pages 180-183.
Crossref
Crossref
Amir Aziz, Shabeena Aziz & Stephen B. Wheatcroft. (2013) Novel anti-thrombotic therapy in acute coronary syndromes. Cor et Vasa 55:2, pages e117-e125.
Crossref
Crossref
Koo WilsonRobert HettleSophie MarbaixSilvia Diaz CerezoMonica InesLaura SantoniLieven AnnemansJacques PrignotEsteban Lopez de Sa. (2011) An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy. European Journal of Preventive Cardiology 19:5, pages 1173-1183.
Crossref
Crossref
Dennis H. M. Kusters, Jan Tegtmeier, Leon J. Schurgers & Chris P. M. Reutelingsperger. (2012) Molecular Imaging to Identify the Vulnerable Plaque—From Basic Research to Clinical Practice. Molecular Imaging and Biology 14:5, pages 523-533.
Crossref
Crossref
AMEET BAKHAI, JEAN FERRIERES, ANDRES IÑIGUEZ, MAGALI SARTRAL, MARK BELGER, CLAUDE SCHMITT & UWE ZEYMER. (2011) Clinical Outcomes, Resource Use, and Costs at 1 Year in Patients with Acute Coronary Syndrome Undergoing PCI: Results from the Multinational APTOR Registry. Journal of Interventional Cardiology 25:1, pages 19-27.
Crossref
Crossref
Thomas Reinhold, Claudia Lindig, Stefan N. Willich & Bernd Brüggenjürgen. (2011) The costs of myocardial infarction—a longitudinal analysis using data from a large German health insurance company. Journal of Public Health 19:6, pages 579-586.
Crossref
Crossref
Philip Haaf, Cathrin Balmelli, Tobias Reichlin, Raphael Twerenbold, Miriam Reiter, Julia Meissner, Nora Schaub, Claudia Stelzig, Michael Freese, Patricia Paniz, Christophe Meune, Beatrice Drexler, Heike Freidank, Katrin Winkler, Willibald Hochholzer & Christian Mueller. (2011) N-terminal Pro B-type Natriuretic Peptide in the Early Evaluation of Suspected Acute Myocardial Infarction. The American Journal of Medicine 124:8, pages 731-739.
Crossref
Crossref
C. Piñol, E. Alegría & S. Langham. (2011) Carga epidemiológica y económica de la hipertensión arterial en pacientes con síndrome metabólico en España: un modelo basado en la prevalencia. Hipertensión y Riesgo Vascular 28:4, pages 126-136.
Crossref
Crossref
C. Lucioni, S. Mazzi, M. Gozzo & C. Lazzeri. (2013) Valutazione economica di ticagrelor vs Clopidogrel nel trattamento di pazienti con sindrome coronarica acutaEconomic evaluation of ticagrelor vs Clopidogrel in ACS patients. PharmacoEconomics Italian Research Articles 13:2, pages 53-64.
Crossref
Crossref
Eberhard Wille, Jürgen Scholze, Eduardo Alegria, Claudio Ferri, Sue Langham, Warren Stevens, David Jeffries & Kerstin Uhl-Hochgraeber. (2010) Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy. The European Journal of Health Economics 12:3, pages 205-218.
Crossref
Crossref
K. Damm, C. Runge, U. Zeymer & J.-M. Graf von der Schulenburg. (2011) Krankheitskosten des akuten Koronarsyndroms in DeutschlandCost of illness of acute coronary syndrome in Germany. Der Kardiologe 5:2, pages 122-128.
Crossref
Crossref
Jean Ferrières, Magali Sartral, Stéphanie Tcherny-Lessenot & Mark Belger. (2011) A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in Europe. Archives of Cardiovascular Diseases 104:2, pages 104-114.
Crossref
Crossref
Jürgen Scholze, Eduardo Alegria, Claudio Ferri, Sue Langham, Warren Stevens, David Jeffries & Kerstin Uhl-Hochgraeber. (2010) Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model. BMC Public Health 10:1.
Crossref
Crossref
Heiko Friedel, Anne Delges, Johannes Clouth & Dana T. Trautvetter. (2009) Expenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary intervention. The European Journal of Health Economics 11:5, pages 449-455.
Crossref
Crossref
J Greenhalgh, A Bagust, A Boland, CM Saborido, N Fleeman, C McLeod, Y Dundar, R Dickson, C Proudlove, R Kolamunnage-Dona & M Fisher. (2010) Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention. Health Technology Assessment 14:Suppl 1, pages 31-38.
Crossref
Crossref
M. J. Alberts, D. L. Bhatt, J.-L. Mas, E. M. Ohman, A. T. Hirsch, J. Rother, G. Salette, S. Goto, S. C. Smith, C.-S. Liau, P. W.F. Wilson & Ph. G. Steg. (2009) Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. European Heart Journal 30:19, pages 2318-2326.
Crossref
Crossref
Björn Schwander, Birgit Gradl, York Zöllner, Peter Lindgren, Hans-Christoph Diener, Stephan Lüders, Joachim Schrader, Fernando Antoñanzas Villar, Wolfgang Greiner & Bengt Jönsson. (2009) Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model. Value in Health 12:6, pages 857-871.
Crossref
Crossref
Doreen McBride, Anna M. Mattenklotz, Stefan N Willich & Bernd Brüggenjürgen. (2009) The Costs of Care in Atrial Fibrillation and the Effect of Treatment Modalities in Germany. Value in Health 12:2, pages 293-301.
Crossref
Crossref
Dominik Ketelsen, Marie H. Luetkhoff, Christoph Thomas, Matthias Werner, Markus Buchgeister, Ilias Tsiflikas, Anja Reimann, Christof Burgstahler, Andreas F. Kopp, Claus D. Claussen & Martin Heuschmid. (2008) Estimation of the radiation exposure of a chest pain protocol with ECG-gating in dual-source computed tomography. European Radiology 19:1, pages 37-41.
Crossref
Crossref
U. Srinivas-Shankar, J.D. Somauroo, A.-M. Delduca, T.S. Jordan, S.A. Bowles & M.K. Rutter. (2008) Temporal change in glucose tolerance in non-ST-elevation myocardial infarction. Diabetes Research and Clinical Practice 82:3, pages 310-316.
Crossref
Crossref
Marie KruseMichael Davidsen, Mette Madsen, Dorte Gyrd-Hansen & Jan Sørensen. (2008) Costs of heart disease and risk behaviour: Implications for expenditure on prevention. Scandinavian Journal of Public Health 36:8, pages 850-856.
Crossref
Crossref
P. Murabito, F. Rubulotta & A. Gullo. 2008. Anaesthesia, Pain, Intensive Care and Emergency A.P.I.C.E.. Anaesthesia, Pain, Intensive Care and Emergency A.P.I.C.E.
345
404
.